Designed Ankyrin Repeat Proteins provide insights into the structure and function of CagI and are potent inhibitors of CagA translocation by the Helicobacter pylori type IV secretion system

PLoS Pathog. 2023 May 8;19(5):e1011368. doi: 10.1371/journal.ppat.1011368. eCollection 2023 May.

Abstract

The bacterial human pathogen Helicobacter pylori produces a type IV secretion system (cagT4SS) to inject the oncoprotein CagA into gastric cells. The cagT4SS external pilus mediates attachment of the apparatus to the target cell and the delivery of CagA. While the composition of the pilus is unclear, CagI is present at the surface of the bacterium and required for pilus formation. Here, we have investigated the properties of CagI by an integrative structural biology approach. Using Alpha Fold 2 and Small Angle X-ray scattering, it was found that CagI forms elongated dimers mediated by rod-shape N-terminal domains (CagIN) prolonged by globular C-terminal domains (CagIC). Three Designed Ankyrin Repeat Proteins (DARPins) K2, K5 and K8 selected against CagI interacted with CagIC with subnanomolar affinities. The crystal structures of the CagI:K2 and CagI:K5 complexes were solved and identified the interfaces between the molecules, thereby providing a structural explanation for the difference in affinity between the two binders. Purified CagI and CagIC were found to interact with adenocarcinoma gastric (AGS) cells, induced cell spreading and the interaction was inhibited by K2. The same DARPin inhibited CagA translocation by up to 65% in AGS cells while inhibition levels were 40% and 30% with K8 and K5, respectively. Our study suggests that CagIC plays a key role in cagT4SS-mediated CagA translocation and that DARPins targeting CagI represent potent inhibitors of the cagT4SS, a crucial risk factor for gastric cancer development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Bacterial / metabolism
  • Bacterial Proteins / metabolism
  • Designed Ankyrin Repeat Proteins
  • Helicobacter Infections* / microbiology
  • Helicobacter pylori* / metabolism
  • Humans
  • Type IV Secretion Systems / genetics
  • Type IV Secretion Systems / metabolism

Substances

  • Bacterial Proteins
  • Antigens, Bacterial
  • Type IV Secretion Systems
  • Designed Ankyrin Repeat Proteins

Grants and funding

The project was funded by ANR grants ANR-Subsist (ANR- 19-CE11-0012). JG salary was provided by ANR- 19-CE11-0012. The study was also funded by ANR Sintesys grant ANR-13-ISV3-0006, which provided salary to CB. This work also benefited from support from the Ligue Régionale contre le Cancer, grant number 2017 and Pack Ambition Rhône-Auvergne Région 2020 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.